Baird Medical Investment Holdings Limited is a medical devices company specializing in microwave ablation technology for minimally invasive tumor treatment. The company develops and manufactures microwave ablation apparatus, needles, and related medical devices used to treat benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, breast lumps, and bone lesions. Operating primarily in the People's Republic of China, Baird Medical positions its microwave ablation systems as safer alternatives to traditional surgical approaches, offering patients faster recovery times and lower complication rates. The company's products are FDA 510(k)-certified and have been deployed across hospitals and clinics internationally. Baird Medical distributes its microwave ablation devices and consumables through third-party distributors and maintains a focus on expanding its presence in minimally invasive medical interventions. The company also pursues research and development initiatives in surgical robotics and intelligent diagnostic systems to complement its core medical device business.